Close

Miss Veronica Di Carlo

Research Fellow

United Kingdom

I graduated in Economics from the University of Salerno (Italy) in 2012 and then completed a Masters in Statistics at the University of Bologna (Italy) in 2014.

I joined the Cancer Survival Group in 2015 and I’m working in the CONCORD programme since then.

In 2018, I also started a part-time PhD aiming to explain global variation in population-based survival from malignant melanoma.

Affiliations

Department of Non-communicable Disease Epidemiology
Faculty of Epidemiology and Population Health

Teaching

Statistical Methods in Epidemiology (2402)

Statistics for EPH (2402),

Cancer survival: principles, methods and analysis (short course)

Research

My main research interests are in international comparisons of population-based cancer survival, which are designed to measure the comparative effectiveness of health systems in cancer control, and thus to influence cancer control policy.

I'm particularly interested in explaining the wide global variation in population-based survival from malignant melanoma in countries partecipating in the CONCORD programme.

I am part of the CONCORD and VENUSCANCER Central Analytic Team. VENUSCANCER is a high-resolution study aiming at explaining the reasons for world-wide disparities in survival for women's cancer by looking at detailed information on tumour biology, stage, staging procedures, treatments and socio-economic variables.

I’m also involved in the modelling of life tables for countries participating in the CONCORD study by applying a new multivariable, flexible model developed in the Cancer Survival Group to estimate complete, smoothed life tables for sub-national populations.

Selected Publications

Does the morphology of cutaneous melanoma help to explain the international differences in survival? Results from 1 578 482 adults diagnosed during 2000-2014 in 59 countries (CONCORD-3).
DI CARLO, V; Stiller, CA; Eisemann, N; Bordoni, A; MATZ, M; Curado, MP; Daubisse-Marliac, L; Valkov, M; Bulliard, J-L; Morrison, D; Johnson, C; GIRARDI, F; Marcos-Gragera, R; Šekerija, M; Larønningen, S; Sirri, E; COLEMAN, MP; ALLEMANI, C; CONCORD Working Group,;
2022
The British journal of dermatology
Trends in short-term survival from distant-stage cutaneous melanoma in the United States, 2001-2013 (CONCORD-3).
DI CARLO, V; Estève, J; Johnson, C; GIRARDI, F; Weir, HK; Wilson, RJ; MINICOZZI, P; Cress, RD; Lynch, CF; Pawlish, KS; Rees, JR; COLEMAN, MP; ALLEMANI, C; US CONCORD Working Group,;
2020
JNCI cancer spectrum
Sustainable care for children with cancer: a Lancet Oncology Commission.
Atun, R; Bhakta, N; Denburg, A; Frazier, AL; Friedrich, P; Gupta, S; Lam, CG; Ward, ZJ; Yeh, JM; ALLEMANI, C; COLEMAN, MP; DI CARLO, V; Loucaides, E; FITCHETT, E; GIRARDI, F; Horton, SE; Bray, F; Steliarova-Foucher, E; Sullivan, R; Aitken, JF; Banavali, S; Binagwaho, A; Alcasabas, P; Antillon, F; Arora, RS; ... Rodriguez-Galindo, C.
2020
The Lancet Oncology
Global surveillance of trends in cancer survival 2000-14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries.
ALLEMANI, C; Matsuda, T; DI CARLO, V; HAREWOOD, R; MATZ, M; NIKŠIĆ, M; BONAVENTURE, A; Valkov, M; Johnson, CJ; Estève, J; Ogunbiyi, OJ; Azevedo E Silva, G; Chen, W-Q; Eser, S; Engholm, G; Stiller, CA; Monnereau, A; Woods, RR; Visser, O; Lim, GH; Aitken, J; Weir, HK; COLEMAN, MP; CONCORD Working Group,;
2018
Lancet
Global survival trends for brain tumors, by histology: Analysis of individual records for 67,776 children diagnosed in 61 countries during 2000-2014 (CONCORD-3).
GIRARDI, F; DI CARLO, V; Stiller, C; Gatta, G; Woods, RR; Visser, O; Lacour, B; Tucker, TC; COLEMAN, MP; ALLEMANI, C; CONCORD Working Group,;
2022
Neuro-oncology
Worldwide trends in population-based survival for children, adolescents, and young adults diagnosed with leukaemia, by subtype, during 2000-14 (CONCORD-3): analysis of individual data from 258 cancer registries in 61 countries.
SSENYONGA, N; Stiller, C; Nakata, K; Shalkow, J; Redmond, S; Bulliard, J-L; GIRARDI, F; Fowler, C; Marcos-Gragera, R; Bonaventure, A; Saint-Jacques, N; Minicozzi, P; De, P; Rodríguez-Barranco, M; Larønningen, S; Di Carlo, V; Mägi, M; Valkov, M; Seppä, K; Wyn Huws, D; COLEMAN, MP; ALLEMANI, C; CONCORD Working Group,;
2022
The Lancet Child & Adolescent Health
Is short-term survival from metastatic cutaneous melanoma improving? Results from 22 countries (CONCORD-3).
DI CARLO, V; MATZ, M; MINICOZZI, P; SSENYONGA, N; COLEMAN, M; ALLEMANI, C;
2021
International Association of Cancer Registries
World-wide trends in survival for children, adolescents and young adults (0-24 years) diagnosed with leukaemia during 2000-2014 in 61 countries (CONCORD-3).
SSENYONGA, N; DI CARLO, V; GIRARDI, F; MATZ, M; MINICOZZI, P; COLEMAN, M; ALLEMANI, C;
2021
International Association of Cancer Registries (IACR)
The histology of brain tumors for 67 331 children and 671 085 adults diagnosed in 60 countries during 2000-2014: a global, population-based study (CONCORD-3).
GIRARDI, F; Rous, B; Stiller, CA; Gatta, G; Fersht, N; Storm, HH; Rodrigues, JR; Herrmann, C; Marcos-Gragera, R; Peris-Bonet, R; Valkov, M; Weir, HK; Woods, RR; You, H; Cueva, PA; De, P; DI CARLO, V; Johannesen, TB; Lima, CA; Lynch, CF; COLEMAN, MP; ALLEMANI, C; CONCORD Working Group,;
2021
Neuro-oncology
Exploring the reasons for the persistent cancer survival gap between the UK and Australia, Canada, Denmark, Norway and Sweden
ALLEMANI, C; DI CARLO, V; MATZ, M; COLEMAN, M;
2019
Joint North American Association of Central Cancer Registries (NAACCR) / International Association of Cancer Registries (IACR) conference
See more information